305 related articles for article (PubMed ID: 17236203)
1. Twist, a novel oncogene, is upregulated in pancreatic cancer: clinical implication of Twist expression in pancreatic juice.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Int J Cancer; 2007 Apr; 120(8):1634-40. PubMed ID: 17236203
[TBL] [Abstract][Full Text] [Related]
2. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
3. S100P is an early developmental marker of pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
[TBL] [Abstract][Full Text] [Related]
4. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
5. Effect of Twist and Bmi1 on intraductal papillary mucinous neoplasm of the pancreas.
Ishikawa D; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S; Miyake H
J Gastroenterol Hepatol; 2014 Dec; 29(12):2032-7. PubMed ID: 24909638
[TBL] [Abstract][Full Text] [Related]
6. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
[TBL] [Abstract][Full Text] [Related]
7. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
8. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
[TBL] [Abstract][Full Text] [Related]
9. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
12. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Satoh K; Hamada S; Kanno A; Hirota M; Umino J; Ito H; Masamune A; Egawa S; Unno M; Shimosegawa T
J Gastroenterol; 2010 Jul; 45(7):763-70. PubMed ID: 20107842
[TBL] [Abstract][Full Text] [Related]
13. Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients undergoing pancreatoduodenectomy.
Sanyal S; Siriwardena AK; Byers R
Pancreatology; 2018 Jun; 18(4):458-462. PubMed ID: 29574096
[TBL] [Abstract][Full Text] [Related]
14. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
[TBL] [Abstract][Full Text] [Related]
15. LIM only 4 is overexpressed in late stage pancreas cancer.
Yu J; Ohuchida K; Nakata K; Mizumoto K; Cui L; Fujita H; Yamaguchi H; Egami T; Kitada H; Tanaka M
Mol Cancer; 2008 Dec; 7():93. PubMed ID: 19099607
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice.
Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Maekawa S; Mochizuki K; Kawaida H; Itakura J; Katoh R; Fujii H; Sato T; Enomoto N
Pancreas; 2017; 46(10):1281-1287. PubMed ID: 28930868
[TBL] [Abstract][Full Text] [Related]
17. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer.
Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Maekawa S; Mochizuki K; Kawaida H; Kono H; Itakura J; Sato T; Ichikawa D; Enomoto N
Pancreas; 2019 Sep; 48(8):1032-1040. PubMed ID: 31404021
[TBL] [Abstract][Full Text] [Related]
18. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms.
Yu J; Sadakari Y; Shindo K; Suenaga M; Brant A; Almario JAN; Borges M; Barkley T; Fesharakizadeh S; Ford M; Hruban RH; Shin EJ; Lennon AM; Canto MI; Goggins M
Gut; 2017 Sep; 66(9):1677-1687. PubMed ID: 27432539
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.
Keleg S; Titov A; Heller A; Giese T; Tjaden C; Ahmad SS; Gaida MM; Bauer AS; Werner J; Giese NA
PLoS One; 2014; 9(6):e100178. PubMed ID: 24932730
[TBL] [Abstract][Full Text] [Related]
20. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
